Abstract 14911: Induction Of Regression Of Atherosclerosis By The LXR-agonist R211945-a Multimodality Non-invasive Assessment And Comparison With Atorvastatin

Esad Vucic,Claudia Calcagno,Steve Dickson,James H Rudd,Katsumi Hayashi,Jan Bucerius,Erin Moshier,Jessica S. Mounessa,Michelle Roytman,Matthew J. Moon,James Lin,Tatsuo Tanimoto,Karen Brown,Masakatsu Kotsuma,Sotirios Tsimikas,Edward A. Fisher,Klaas Nicolay,Valentin Fuster,Zahi A. Fayad

Abstract 14911: Induction Of Regression Of Atherosclerosis By The LXR-agonist R211945-a Multimodality Non-invasive Assessment And Comparison With Atorvastatin

2011

Esad Vucic
Claudia Calcagno
Steve Dickson
James H Rudd
Katsumi Hayashi
Jan Bucerius
Erin Moshier
Jessica S. Mounessa
Michelle Roytman
Matthew J. Moon
James Lin
Tatsuo Tanimoto
Karen Brown
Masakatsu Kotsuma
Sotirios Tsimikas
Edward A. Fisher
Klaas Nicolay
Valentin Fuster
Zahi A. Fayad

Background: Liver-x-receptor (LXR)-agonists induce reversal cholesterol transport and modulate inflammation. Objective: R211945, an LXR-agonist, promotes reverse cholesterol transport while mitigat...

Keywords:

Inflammation
Liver X receptor
Reverse cholesterol transport
Internal medicine
Atorvastatin
Cardiology
Agonist
Diabetes mellitus
Pharmacology
Cholesterol
Medicine
non invasive

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations